Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amdoxovir vs Tenofovir DF in HIV-1
NCT01737359Phase 2Terminated
- Sponsor
- RFS Pharma
- Start
- Dec 2012
- Primary completion
- Feb 2013
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of amdoxovir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by RFS Pharma. Started Dec 2012; status: terminated.
02
Drugs
amdoxovir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01737359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01737359.